Question 1

Has Myron Reiff received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $329,024 in general payments to Myron Reiff across 48 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Myron Reiff did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Myron Reiff come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Imbrium Therapeutics L.p.	21	$296,611
F. Hoffmann-la Roche AG	5	$14,000
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$12,209
Genentech, Inc.	1	$4,128
Modernatx, Inc.	9	$1,816
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$160
Axsome Therapeutics, Inc.	2	$65
Merck	1	$35

Myron Reiff

Payments from drug & device makers

Who reported the general payments

How this compares

Other family medicine in Tustin